Longitudinal Assessment of an ELISPOT Test for Mycobacterium tuberculosis Infection
Open Access
- 12 June 2007
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 4 (6) , e192
- https://doi.org/10.1371/journal.pmed.0040192
Abstract
Very little longitudinal information is available regarding the performance of T cell-based tests for Mycobacterium tuberculosis infection. To address this deficiency, we conducted a longitudinal assessment of the enzyme-linked immunosorbent spot test (ELISPOT) test in comparison to the standard tuberculin skin test (TST). In tuberculosis (TB) contacts we repeated ELISPOT tests 3 mo (n = 341) and 18 mo (n = 210) after recruitment and TSTs at 18 mo (n = 130). We evaluated factors for association with conversion and reversion and investigated suspected cases of TB. Of 207 ELISPOT-negative contacts, 51 (24.6%) had 3-mo ELISPOT conversion, which was associated with a positive recruitment TST (odds ratio [OR] 2.2, 95% confidence interval [CI] 1.0–5.0, p = 0.048) and negatively associated with bacillus Calmette-Guérin (BCG) vaccination (OR 0.5, 95% CI 0.2–1.0, p = 0.06). Of 134 contacts, 54 (40.2%) underwent 3-mo ELISPOT reversion, which was less likely in those with a positive recruitment TST (OR 0.3, 95% CI 0.1–0.8, p = 0.014). Between 3 and 18 mo, 35/132 (26.5%) contacts underwent ELISPOT conversion and 28/78 (35.9%) underwent ELISPOT reversion. Of the 210 contacts with complete results, 73 (34.8%) were ELISPOT negative at all three time points; 36 (17.1%) were positive at all three time points. Between recruitment and 18 mo, 20 (27%) contacts had ELISPOT conversion; 37 (50%) had TST conversion, which was associated with a positive recruitment ELISPOT (OR 7.2, 95% CI 1.4–37.1, p = 0.019); 18 (32.7%) underwent ELISPOT reversion; and five (8.9%) underwent TST reversion. Results in 13 contacts diagnosed as having TB were mixed, but suggested higher TST sensitivity. Both ELISPOT conversion and reversion occur after M. tuberculosis exposure. Rapid ELISPOT reversion may reflect M. tuberculosis clearance or transition into dormancy and may contribute to the relatively low reported ELISPOT conversion rate. Therefore, a negative ELISPOT test for M. tuberculosis infection should be interpreted with caution.Keywords
This publication has 32 references indexed in Scilit:
- Dynamic Antigen-specific T-Cell Responses after Point-Source Exposure toMycobacterium tuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Serial Testing of Health Care Workers for Tuberculosis Using Interferon-γ AssayAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Recognition of Stage-Specific Mycobacterial Antigens Differentiates between Acute and Latent Infections with Mycobacterium tuberculosisClinical and Vaccine Immunology, 2006
- Effect of Treatment of Latent Tuberculosis Infection on the T Cell Response toMycobacterium tuberculosisAntigensThe Journal of Infectious Diseases, 2006
- Enzyme-Linked Immunospot Assay Responses to Early Secretory Antigenic Target 6, Culture Filtrate Protein 10, and Purified Protein Derivative among Children with Tuberculosis: Implications for Diagnosis and Monitoring of TherapyClinical Infectious Diseases, 2005
- Large‐Scale Evaluation of Enzyme‐Linked Immunospot Assay and Skin Test for Diagnosis ofMycobacterium tuberculosisInfection against a Gradient of Exposure in The GambiaClinical Infectious Diseases, 2004
- Use of a T Cell–Based Assay for Monitoring Efficacy of Antituberculosis TherapyClinical Infectious Diseases, 2004
- Evaluation of a Whole‐Blood Interferon‐γ Release Assay for the Detection ofMycobacterium tuberculosisInfection in 2 Study PopulationsClinical Infectious Diseases, 2002
- Nonreplicating Persistence ofMycobacteriumTuberculosisAnnual Review of Microbiology, 2001
- Interpretation of Repeated Tuberculin TestsAmerican Journal of Respiratory and Critical Care Medicine, 1999